Hepatic adenoma, also referred to as HCA, is an uncommon non-cancerous growth found in the liver, composed of epithelial cells. These growths, known as hepatocellular adenomas or hepadenomas, typically occur in individuals with otherwise healthy livers. The development of hepatic adenomas is heavily influenced by hormones, with a notable relationship between the dosage and duration of hormonal therapy and the formation of these tumors.
Risk Factors Associated with Hepatic Adenoma
Hepatic adenoma, a benign tumor of the liver, is influenced by various risk factors, some of which are discussed below:
1. Long-term use of oral contraceptives and hormonal therapy: Prolonged usage of oral contraceptives and hormonal therapy is considered the most significant risk factor for developing hepatic adenoma.
2. Metabolic diseases: Certain metabolic disorders, including tyrosinemia, glycogen storage disease, and type 1 diabetes mellitus, are associated with an increased risk of hepatic adenoma.
3. Medications affecting circulating hormones: Certain medications, such as barbiturates and anabolic or androgenic steroids, can also have a slight impact on hormone levels and thereby contribute to the development of hepatic adenoma.
It is important to be aware of these risk factors and to consult with a healthcare professional for appropriate guidance and monitoring.
Symptoms of Hepatic Adenoma
Hepatic adenomas (HCAs) primarily develop in the right hepatic lobe. While less than half of individuals with an HCA experience pain, many remain asymptomatic. However, if the tumor grows significantly, a noticeable mass may become apparent. It is important to note that usually only one hepatic adenoma develops in the liver. If multiple benign tumors are present throughout the liver, it is a separate condition known as liver cell adenomatosis. The cause of liver cell adenomatosis does not appear to be related to contraceptive use or hormonal changes.